8-K: Microbot Medical to Host Conference Call on LIBERTY System Progress

Microbot Medical Inc. announced a conference call for May 18th to discuss the LIBERTY Endovascular Robotic System's progress and address recent third-party article inaccuracies.

Summary

• Microbot Medical Inc. will host an analysts and investors conference call on Monday, May 18th, 2026, at 3:00 PM ET.
• The call will review the recent progress of the Full Market Release (FMR) of the LIBERTY Endovascular Robotic System.
• The company aims to correct misleading statements and misrepresentations made in a recent unaffiliated third-party article.
• Key executives, including Chairman, CEO & President Harel Gadot, will be joined by Dr. Charles Briggs (vascular surgeon and LIBERTY user) and Dr. Zachary L. Bercu (interventional radiologist and first LIBERTY user).
• Dr. Briggs will address inaccuracies attributed to him in the third-party article.
• Dr. Bercu will discuss his experience using the LIBERTY System in everyday practice.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily serves to announce a conference call to address potential misinformation rather than presenting new financial results or strategic developments.

Positives

• The company is proactively addressing potential misinformation and ensuring investors are accurately informed.
• Key opinion leaders and users of the LIBERTY System will provide direct testimonials and address inaccuracies.
• The conference call provides an opportunity to highlight the progress of the LIBERTY System's Full Market Release.

Negatives

• The need to correct 'misleading statements and misrepresentations' from a third-party article suggests potential negative publicity or investor confusion.
• The involvement of users addressing 'inaccuracies attributed to him' indicates a dispute or misunderstanding that needs clarification.

Risks

• Market conditions and risks inherent in the commercialization of the LIBERTY Endovascular Robotic System.
• Uncertainty in regulatory pathways and approvals.
• Disruptions from geopolitical conditions, including hostilities and potential tariffs.
• Maintenance of intellectual property rights.

Future Outlook

The company's forward-looking statements mention future financial and/or operating results, future adoption of products, future growth in research, technology, clinical development, commercialization, and potential opportunities. However, specific financial guidance is not provided in this filing.

Management Comments

• The company aims to ensure the investing public is correctly and fully informed on company and product information that was recently misrepresented by a recent unaffiliated third-party article.
• Dr. Charles Briggs will address certain inaccuracies attributed to him, which were recently made by an unaffiliated third party in their article.
• Dr. Zachary L. Bercu will discuss the experience of utilizing the LIBERTY System in the everyday practice of their interventional radiology department.

Industry Context

StockSavvy.ai notes that Microbot Medical's proactive approach to addressing third-party article inaccuracies and hosting a conference call with key users highlights the importance of clear communication and reputation management in the competitive medical device sector, particularly for companies commercializing novel robotic systems.

Stakeholder Impact

• Shareholders: The call aims to provide clarity and potentially mitigate negative impacts from misinformation, fostering investor confidence.
• Investors: Will receive direct information from management and key users to better understand the LIBERTY System's progress and address concerns.
• Medical Professionals: Users will have an opportunity to share their experiences and correct any misattributed statements.

Next Steps

• Host analysts and investors conference call on May 18th, 2026.
• Review recent progress of the LIBERTY System's Full Market Release.
• Correct misleading statements and misrepresentations from a third-party article.
• Provide insights from users of the LIBERTY System.

Key Dates

Keywords

Microbot Medical, LIBERTY Endovascular Robotic System, FMR, conference call, investor relations, vascular surgeon, interventional radiologist, medical device